We have developed the world's first discovery of vascular-specific stem cells as cell therapy, providing groundbreaking solutions for the patients suffering from unresolved microvascular diseases.
Our patented seed technology, vascular endothelial stem cells, is distributed in blood vessels throughout the body and is essential for the maintenance and regeneration of blood vessels in the body.
We provide novel solutions for many microvascular diseases through two therapeutic concepts. The first is angiogenesis therapy, which can be applied to digital ulcers of systemic sclerosis, diabetic wounds, critical limb ischemia, vascular dementia, breast reconstruction, etc. The second, with angiocrine therapy, it is possible to completely cure hemophilia and lysosomal storage disorder through cell transplantation.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 3-1 Yamadaoka, Suita-Shi,osaka 565-0871,japan
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.revascularbio.com
- Keywords
- cell therapy, chronic wound, critical limb ischemia, Hemophilia, microvascular disease, vascular dementia.
- HQ
- Suita-shi, Osaka
Revascular Bio Questions
Revascular Bio's website is https://www.revascularbio.com
Revascular Bio's LinkedIn profile is https://jp.linkedin.com/company/revascular-bio
Revascular Bio has
2 employees.
View email and phone details for 2
employees at Revascular Bio.
Revascular Bio's industry is
Pharmaceutical Manufacturing
Revascular Bio's top competitors are
Saisei Ventures,
Gut Feelings Psychosomatic Medicine,
Kotai Biotechnologies, Inc.,
Luxna Biotech Co., Ltd.,
Nextvivo,
Kiko Tech Co.,ltd,
Mirai Innovation Research Institute,
Attp (The Alliance Of Technology Transfer Professionals),
Nuanced Health,
Fet Open Gladiator.
Revascular Bio's categories are Pharmaceutical Manufacturing
Revascular Bio's founding year is 2022
